ADAM9 and breast carcinoma: The results indicated that high ADAM9 mRNA expression was significantly correlated with poor OS (Figure 3A, p < 0.01), DMFS (Figure 3B, p < 0.01), and RFS (Figure 3C, p < 0.001) in breast cancer patients.